Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T19:23:07.230Z Has data issue: false hasContentIssue false

Teicoplanin- A New Agent for Gram-Positive Bacterial Infections

Published online by Cambridge University Press:  21 June 2016

Mark Eggleston*
Affiliation:
Howard University, College of Pharmacy and Pharmacal Sciences, Washington, DC
Joseph Ofosu
Affiliation:
Howard University, College of Pharmacy and Pharmacal Sciences, Washington, DC
*
PO Box 115, Woodbridge, VA 22191

Extract

Gram-positive bacterial infections remain a serious challenge for infectious disease practitioners. Many gram-positive organisms are developing new methods of antibiotic resistance, thus rendering our standard antimicrobial agents ineffective. Penicillin G resistance, methicillin-resistant Staphylococcus aureus and recently, a laboratory strain of vancomycin-resistant S aureus have become catalysts in the search for effective alternatives in the treatment of gram-positive bacterial infections. This review will briefly describe an investigational agent (investigational in the US, although used widely overseas) that has been very successful in treating gram-positive bacterial infections. The antibiotic, named teicoplanin. (Merrell-Dow Pharmaceuticals) may be approved for release in the United States in the future.

Originally known as teichomycin A, teicoplanin is a glycopeptide antibiotic, chemically similar to the vancomycin-ristocetin antibiotic group. Teicoplanin was discovered following the fermentation process of Actinoplanes teichomyceticus The antibiotic has a linear heptapeptide structure and weighs approximately 2000 daltons.

Information

Type
Special Sections
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable